Influenza vaccine [inactivated] — Competitive Intelligence Brief

Influenza vaccine [inactivated] (Influenza vaccine [inactivated]) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Inactivated vaccine. Area: Immunology / Infectious Disease.

phase 3 Inactivated vaccine Immunology / Infectious Disease Biologic

Target snapshot

Influenza vaccine [inactivated] (Influenza vaccine [inactivated]) — St. Petersburg Research Institute of Vaccines and Sera. An inactivated influenza vaccine stimulates the immune system to produce antibodies and cellular immunity against influenza virus strains without causing infection.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Influenza vaccine [inactivated] TARGET	Influenza vaccine [inactivated]	St. Petersburg Research Institute of Vaccines and Sera	phase 3	Inactivated vaccine
GamEvac-Combi (vaccine)	GamEvac-Combi (vaccine)	Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation	marketed	Combination inactivated vaccine
Quadrivalent Influenza Vaccine	Quadrivalent Influenza Vaccine	International Centre for Diarrhoeal Disease Research, Bangladesh	marketed	Inactivated vaccine	Influenza viruses
Seasonal Inactivated Influenza Vaccine	Seasonal Inactivated Influenza Vaccine	Pfizer	marketed	Inactivated vaccine
Qiv	qiv	Pfizer	marketed	Inactivated vaccine	Influenza viruses
Trivalent Inactivated Vaccine	Trivalent Inactivated Vaccine	McMaster University	marketed	Inactivated vaccine
DTacP-IPV combined vaccine (TETRAXIM™)	DTacP-IPV combined vaccine (TETRAXIM™)	Sanofi	marketed	Combination inactivated vaccine	Diphtheria toxin, tetanus toxin, Bordetella pertussis antigens (PT, FHA, PRN), poliovirus types 1, 2, and 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Inactivated vaccine class)

1. Pfizer · 3 drugs in this class
2. McMaster University · 1 drug in this class
3. Sanofi Pasteur, a Sanofi Company · 1 drug in this class
4. Sinovac Biotech Co., Ltd · 1 drug in this class
5. St. Petersburg Research Institute of Vaccines and Sera · 1 drug in this class
6. The University of Hong Kong · 1 drug in this class
7. International Centre for Diarrhoeal Disease Research, Bangladesh · 1 drug in this class
8. Vac4All · 1 drug in this class